Less Ads, More Data, More Tools Register for FREE

Pin to quick picksC&C Group Regulatory News (CCR)

Share Price Information for C&C Group (CCR)

Share Price is delayed by 15 minutes
Get Live Data
94.50    2.30 (2.49%)
Bid:
94.10
Ask:
94.40
Spread: 0.30 (0.319%)
Market Cap: £348.08m
CCR Live PriceLast checked at - London Stock Exchange

Intraday C&C Group Share Chart

Director/PDMR Shareholding

4 Nov 2020 14:15

RNS Number : 2789E
C&C Group Plc
04 November 2020
 

C&C Group plc

 

Notification of Transactions by Persons Discharging Managerial Responsibilities and Persons Closely Associated with them

 

On 3 November 2020, the Company approved the grant to David Forde of two awards in the form of nil-cost options over ordinary shares in the Company. These awards are compensation for remuneration arrangements forfeited by David Forde on leaving his previous employer and were agreed as part of his recruitment package, as announced on 9 July 2020.

 

Buy-Out Award

Number of Shares

Vesting Date

Buy-Out Award 1

421,318

3 November 2022

Buy-Out Award 2

421,318

3 November 2023

 

The share price used to calculate the number of awards was the mid-market closing price on the dealing day prior to grant (2 November 2020). The awards will vest on the dates provided above, subject to Mr Forde's continued service with the Company.

 

The awards have been granted in reliance on FCA Listing Rule 9.4.2(2). As noted in the announcement of 9 July, the full terms of Mr Forde's remuneration package will be included in the Company's Directors' Remuneration Report for the year ending in 2021.

 

Contact

 

Mark Chilton, Company Secretary

C&C Group plc

Bulmers House

Keeper Road

Crumlin

Dublin 12

D12 K702

 

 1

Details of the person discharging managerial responsibilities/person closely associated 

a)

Name

David Forde

2

Reason for the notification 

a)

Position/status

Person Discharging Managerial Responsibilities (Chief Executive Officer)

b)

Initial Notification Amendment

Initial Notification

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

C&C Group plc

b)

LEI

635400LNUHA2LDXXV850 

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument

Ordinary Shares of €0.01 each

Identification code

ISIN: IE00B010DT83

b)

Nature of the transaction

Grant of options to acquire Ordinary Shares of €0.01 each

c)

Price(s) and volume(s)

Price(s)

Volume(s)

Nil

421,318 ("Buy-Out Award 1")

Nil

421,318 ("Buy-Out Award 2")

d)

Aggregated information

 

- Aggregated volume

 

- Price

 

 

 

842,636

 

Nil

 

e)

Date of the transaction

3 November 2020

f)

Place of the transaction

Outside a trading venue 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DSHEALFLEESEFFA
Date   Source Headline
3rd Jun 20263:59 pmRNSHolding(s) in Company
2nd Jun 20265:19 pmRNSHolding(s) in Company
2nd Jun 202612:04 pmRNSHolding(s) in Company
1st Jun 20266:18 pmRNSTotal Voting Rights
28th May 20264:30 pmRNSHolding(s) in Company
28th May 202610:40 amRNSDirector/PDMR Shareholding
27th May 20264:43 pmRNSHolding(s) in Company
19th May 20263:54 pmRNSDirector/PDMR Shareholding
19th May 20267:00 amRNSFinal Results
8th May 20267:00 amRNSHolding(s) in Company
7th May 20265:28 pmRNSHolding(s) in Company
1st May 20264:28 pmRNSHolding(s) in Company
1st May 20264:25 pmRNSTotal Voting Rights
30th Apr 20264:49 pmRNSHolding(s) in Company
29th Apr 202611:14 amRNSHolding(s) in Company
29th Apr 202611:05 amRNSHolding(s) in Company
16th Apr 20264:37 pmRNSDirector/PDMR Shareholding
9th Apr 202612:12 pmRNSChief Financial Officer Update
1st Apr 202611:58 amRNSTotal Voting Rights
20th Mar 20265:42 pmRNSBoard Committee Membership Update
17th Mar 20263:30 pmRNSDirector/PDMR Shareholding
13th Mar 202612:33 pmRNSHolding(s) in Company
6th Mar 20261:15 pmRNSAcquisition of Innis & Gunn Brand
2nd Mar 202611:31 amRNSTotal Voting Rights
24th Feb 20261:09 pmRNSDirectorate change
18th Feb 202611:56 amRNSDirector/PDMR Shareholding
6th Feb 202612:34 pmRNSDirector/PDMR Shareholding
5th Feb 20267:02 amRNSAppointment of Chief Financial Officer
2nd Feb 202612:55 pmRNSTotal Voting Rights
23rd Jan 20267:00 amRNSFY26 Trading Update
19th Jan 20265:26 pmRNSDirector/PDMR Shareholding
9th Jan 20263:21 pmRNS2025 AGM Voting Update Statement
5th Jan 202611:40 amRNSTotal Voting Rights
23rd Dec 20255:53 pmRNSDirector/PDMR Shareholding
23rd Dec 20255:53 pmRNSDirector/PDMR Shareholding
22nd Dec 20251:12 pmRNSHolding(s) in Company
22nd Dec 20251:12 pmRNSHolding(s) in Company
17th Dec 202512:36 pmRNSDirector/PDMR Shareholding
17th Dec 202512:36 pmRNSDirector/PDMR Shareholding
10th Dec 20256:08 pmRNSHolding(s) in Company
1st Dec 20253:27 pmRNSTotal Voting Rights
26th Nov 202511:40 amRNSHolding(s) in Company
24th Nov 20254:38 pmRNSHolding(s) in Company
19th Nov 20254:46 pmRNSDirector/PDMR Shareholding
19th Nov 202510:45 amRNSDirector/PDMR Shareholding
18th Nov 20253:30 pmRNSDirector/PDMR Shareholding
14th Nov 202511:19 amRNSHolding(s) in Company
13th Nov 20251:45 pmRNSHolding(s) in Company
3rd Nov 20253:09 pmRNSTotal Voting Rights
28th Oct 20257:00 amRNSInterim Results

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.